Zhongyuan xiehe entered the job to check his academic qualifications.

Check. Zhongyuan Sheikh Stem Cell Bioengineering Co., Ltd., referred to as "Zhongyuan Sheikh" for short, undertakes the construction project of national clinical transformation base of stem cell genes, and is the only listed company in Shanghai and Shenzhen stock markets with stem cell industry as its main business. When the company joins the company, it will check the academic qualifications to prevent fraud. It is the first enterprise in China to invest in biological resource storage projects, and also the vice chairman of the national strategic alliance for technological innovation of stem cell and regenerative medicine industry.